Latest news about P&G Hygiene and Health Care
P&G Hygiene and Health Care
9,450.50
+151.50(+1.63%)
Company Performance:
View Company Insights1D+1.63%
1M-6.86%
6M-25.23%
1Y-30.05%
5Y-26.16%
More news about P&G Hygiene and Health Care
27Mar 26
P&G Hygiene and Health Care Board Meeting Scheduled for May 28, 2026 to Review FY26 Results and Final Dividend
Procter & Gamble Hygiene and Health Care Limited has scheduled a board meeting for May 28, 2026 to approve audited financial statements for FY26 ending March 31, 2026 and consider final dividend recommendations. The meeting announcement complies with SEBI Regulation 29 requirements, ensuring transparency with stakeholders. The board will review the company's annual financial performance and make crucial decisions regarding shareholder returns, marking an important milestone in the corporate calendar.
24Feb 26
P&G Hygiene and Health Care Announces Executive Role Transition for Legal Head
Procter & Gamble Hygiene and Health Care Limited announced that Mr. Ghanashyam Hegde, currently Legal Head, Executive Director and Company Secretary, will transition to Vice President & Associate General Counsel – Market Operations covering India, Middle East, Turkey & Africa effective July 1, 2026. The announcement was made to BSE and NSE on February 24, 2026, under SEBI Regulation 30 compliance requirements.
30Jan 26
P&G Hygiene and Health Care Q3FY26 Results: Net Profit Rises 12.2% to ₹301.46 Crore, Declares ₹195 Interim Dividend
P&G Hygiene and Health Care reported strong Q3FY26 results with net profit growing 12.2% YoY to ₹301.46 crore despite marginal revenue growth of 1.1% to ₹1,261.90 crore. The nine-month performance was particularly impressive with net profit surging 25.3% to ₹703.37 crore. The Board declared an interim dividend of ₹195 per share including a ₹25 special dividend, with record date set for February 5, 2026. The company demonstrated effective cost management and operational efficiency across its health care and hygiene product segments.
21Jan 26
P&G Hygiene and Health Care Board Meeting on January 30, 2026 to Consider Interim Dividend Declaration
Procter & Gamble Hygiene and Health Care Limited has scheduled a board meeting for January 30, 2026, to consider declaring an interim dividend for FY2025-26. The announcement was made through a regulatory filing dated January 21, 2026, serving as an update to the company's earlier December 26, 2025 communication. The filing was submitted to both BSE and NSE under Regulation 30 compliance requirements.
06Nov 25
Procter & Gamble Hygiene and Health Care Limited Announces Q2 FY2026 Financial Results
P&G Hygiene and Health Care Ltd (PGHH) announced Q2 FY2026 results with revenue increasing by 1% to ₹1,150.00 crore. However, EBITDA decreased by 5.71% to ₹330.00 crore, and net profit slightly declined by 0.94% to ₹210.00 crore compared to Q2 FY2025. The company maintains a strong financial position with ₹782.10 crore in cash and cash equivalents. PGHH operates in two main segments: Health Care Products and Hygiene Products.
05Sept 25
P&G Hygiene and Health Care Sets Board Meeting for Q3 Results and Interim Dividend Consideration
P&G Hygiene and Health Care has announced a board meeting for February 11, 2025, to review Q3 FY2024-25 financial results and consider an interim dividend. The record date for the potential dividend is set for February 20, 2025. The company recently re-appointed two Non-Executive Independent Directors and a new secretarial auditor at its 61st AGM. P&G Hygiene reported a 3% increase in sales and a 7% rise in PAT for the first nine months of FY2024-25 compared to the previous year.
08Aug 25
Procter & Gamble Hygiene & Health Care Executes ₹100.06 Crore Block Trade on NSE
P&G Hygiene and Health Care executed a significant block trade on the National Stock Exchange (NSE). The transaction involved 75,572 shares traded at ₹13,240.00 per share, totaling ₹100.06 crore. This block trade marks a notable development for the company, a subsidiary of Procter & Gamble, known for its strong presence in the Indian personal care and hygiene products market.
30Jul 25
Procter & Gamble Hygiene & Health Care Reports Robust Q1 Performance with EBITDA Surging 122%
P&G Hygiene and Health Care Ltd. delivered impressive Q1 results, showcasing significant profitability improvements despite modest revenue growth. Revenue increased by 1.08% to ₹9.40 billion, while EBITDA surged by 122% to ₹2.66 billion. The EBITDA margin expanded by 15.71 percentage points to 28.41%. Net profit saw a substantial increase of 136.70% to ₹1.92 billion. These results indicate successful cost management and enhanced operational efficiency, positioning the company strongly in the hygiene and health care sector.
05Jun 25
Procter & Gamble Announces Strategic Divestiture Plans
Procter & Gamble (P&G) has revealed plans for a significant strategic restructuring of its product portfolio, including the divestiture of multiple categories and brands. This move aims to streamline operations and potentially focus on core, high-performing product lines. While specific details about the categories and brands to be divested are not yet disclosed, the restructuring could lead to portfolio optimization, resource reallocation, and market repositioning for P&G. This decision aligns with broader industry trends of reevaluating product portfolios in response to evolving market dynamics and consumer preferences.
05Jun 25
Procter & Gamble Announces Global Workforce Reduction of 7,000 Jobs
Procter & Gamble (P&G) has revealed plans to eliminate 7,000 non-manufacturing jobs worldwide, representing about 15% of its non-manufacturing workforce. This restructuring initiative will be implemented over the next two years as part of a broader strategy to enhance operational efficiency. The impact on P&G's Indian subsidiary, Procter & Gamble Hygiene and Health Care Limited, remains unclear. The company has not provided specific details on how the restructuring will be distributed across different regions or subsidiaries.
27May 25
Procter & Gamble Hygiene and Health Care Reports Slight Profit Increase in Q4, Revenue Dips
Procter & Gamble Hygiene & Health Care's Q4 results show a 1.1% increase in net profit to ₹156.10 crore, despite a 1.05% decrease in revenue to ₹991.63 crore. Total expenses rose by 11.24% to ₹791.10 crore. EBITDA declined by 18.29% to ₹2.10 billion, with the EBITDA margin dropping to 21.21%. The company recommended a dividend of ₹65 per equity share.
26Mar 25
Procter & Gamble Hygiene and Health Care to Review Q4 Results and Consider Dividend on May 27
Procter & Gamble Hygiene and Health Care Limited has announced a board meeting on May 27, 2025, to review Q4 and FY 2025 financial results and consider dividend recommendation. The company's trading window will be closed from April 1, 2025, until 48 hours after the results publication to prevent insider trading.
Industry Peers
Godrej Consumer Products
Dabur India
Colgate PalmoliveP&G Hygiene and Health Care
Gillette
Cupid
Emami
Mamaearth
Bajaj Consumer Care
Anondita Medicare
995.40
(+0.90%)
424.65
(+1.63%)
2,004.40
(-0.70%)
9,450.50
(+1.63%)
7,706.50
(-0.16%)
133.09
(+2.53%)
390.70
(-0.01%)
417.05
(+3.72%)
558.80
(+0.61%)
1,185.55
(+6.10%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
